Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 24 Sept 2026 for Theravance Biopharma, Inc..
Filing timeline
BuySaleDeepika Pakianathan
Insider track record
Disclosed buys
0
Disclosed sells
21
Signal history
Deepika Pakianathan: trading record in brief
Deepika Pakianathan, listed as board member, has filed trades across 7 companies (mainly through SEC (Form 4)), most often in Karyopharm Therapeutics Inc., Theravance Biopharma, Inc. and Mereo BioPharma Group plc. The record holds 41 filings, for trades running from 21 June 2016 to 23 September 2026.
Sales make up the whole of the open-market record (21 sales, €5.2M). Besides market trades, the filings include 6 share grants and 6 option exercises.
The latest filing, published on 24 September 2026, reports a transaction in Theravance Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Deepika Pakianathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
58,065 sharesOrdinary SharesSEC:0001270734-26-000007:0
6,009 sharesOrdinary SharesSEC:0001270734-26-000007:1
10,649 shares0Ordinary SharesSEC:0001415889-25-014022:0
6,492 shares@ US$1.841.9% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-100281:1
12,418 shares@ US$2.725.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-100281:2
38,953 shares@ US$1.318.3% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-100281:3
43,485 shares@ US$0.946.6% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-100281:4
2,071 shares@ US$3.871.3% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-100281:5
105,244 shares@ US$4.429875.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-100281:6
1,825 shares@ US$3.00100.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-100281:0
4,526 shares@ US$0.95820.1% of flowCommon StockSEC:0000950170-24-070991:1
117,307 shares@ US$0.98282.2% of flowCommon StockSEC:0000950170-24-070991:2
1,145 shares@ US$0.98280.0% of flowCommon StockSEC:0000950170-24-070991:3
229,308 shares@ US$0.95074.2% of flowCommon StockSEC:0000950170-24-070991:4
2,240 shares@ US$0.95070.0% of flowCommon StockSEC:0000950170-24-070991:5
463,518 shares@ US$0.958216.0% of flowCommon StockSEC:0000950170-24-070991:0
1,976 shares@ US$0.9540.0% of flowCommon StockSEC:0000950170-24-068969:1
357,256 shares@ US$1.00076.9% of flowCommon StockSEC:0000950170-24-068969:2
3,488 shares@ US$1.00070.1% of flowCommon StockSEC:0000950170-24-068969:3
337,742 shares@ US$0.95216.2% of flowCommon StockSEC:0000950170-24-068969:4
3,298 shares@ US$0.95210.1% of flowCommon StockSEC:0000950170-24-068969:5
202,418 shares@ US$0.9547.0% of flowCommon StockSEC:0000950170-24-068969:0
10,537 shares0Ordinary SharesSEC:0001415889-24-012919:0
9,132 shares0Ordinary SharesSEC:0001415889-23-007384:0
1,172 shares@ US$0.38580.0% of flowCommon StockSEC:0000899243-23-003071:1
25 of 41 declarations
